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ABSTRACT (Maximum 200 Words)
This project was proposed to study the correlation between caspase deficiency and breast cancer carcinogenesis and therapeutic resistance. During the third year, we continued to perform the functional screening of breast cancer cell lines treated with TNF-a and correlate their response with expression status of caspases in the cell lines detected in specific aim 1. Among the 7 breast cancer cell lines detected this year, BT-483, MDA-MB-134VI and MDA-MB-415 cells, which expressed lower levels of caspase 8, were resistant to TNF-t. When 19 breast cancer cell lines were treated with granzyme B, correlation between granzyme B induced apoptosis and caspase levels was less obvious as compared to TNF-a treatment. We have also analyzed sensitivity of 17 breast cancer cell lines treated with radiation and calculated the corresponding ID50 of each cell line. The Radio-sensitivities of these beast cancer cell lines were correlated to these cell lines to certain degree. As predicted, further specific analysis was suggested following these screening experiments. In addition, we found that caspase 3 had feedback actions on apical caspases and mitochondria in response to doxorubicin and TNF-c, implying the critical role of caspase 3 in therapeutic response of breast cancer cells. 14 apoptotic regulators, such as Bax-cc and p53, has been associated with carcinogenesis and therapeutic resistance of breast cancer. Based on the fact that caspases are a group of proteases that mediate apoptotic execution, and that caspase 3 is deficient in MCF-7 breast cancer cells, this project was proposed to study the significance of caspase deficiency in breast cancer carcinogenesis and resistance. The specific aims are:
1. To determine the incidence and pattern of caspase deficiencies in breast cancer via screening for specific caspase expression in breast cancer derived cell lines, explant cultures and snap frozen human breast cancer tissue.
2. Correlation of caspase data (obtained in aim 1) with apoptosis induction using immune modulators (TNF-o, anti-Fas, GrB/Ad), chemotherapeutic agents and radiation on breast cancer derived cell lines and explant cultures.
3. Define the biologic role of specific caspase deficiencies via reconstitution of deficient caspases and comparative studies to define apoptosis induction in response to immune modulators, chemo-and radiation therapy.
In the past year, the PI moved from Evanston Northwestern Healthcare Research Institute/Northwestern University to University of Oklahoma Health Science Center to take a tenure track position as an Assistant Professor. Although the grant money is still in the process of transfer, we tried to continue the work and keep the influence of the transfer on the project progress to a minimum.
In the third year of this project, we performed the experiments as planed in the original proposal.
The major task was to analyze the cell death of different breast cancer cell lines treated with chemotherapeutic agents and radiation (months 23-39). We also continued the functional screening of breast cancer cell lines in response to tumor necrosis factor-cc (TNF-cc) and granzyme/adenovirus (GrB/Ad) treatment. As it was planned, in depth analysis of the effect of caspase 3 deficiency on apoptosis in MCF-7 breast cancer cells was also performed, which belongs to task 4 (months 30-48). Our results have been presented in a national meeting and being prepared for more publications.
Body
The progress of the project is reflected in the following aspects.
A. Functional screening of breast cancer cell lines in response to TNF-cc and GrB/Ad treatment (specific aim 2, task 2)
According to the proposal, these experiments were designed to examine the susceptibility of different breast cancer cell lines in response to cytokines and granzyme B. The apoptotic response of the treated cells would be correlated with caspase expression profiles derived in specific aim 1. deficiency was related to the resistance to GrB mediated apoptosis (2) . To correlate caspase expression status and GrB mediated apoptosis, we treated different breast cancer cell lines with GrB and Ad (replication defective type 2 adenovirus was used to deliver GrB).
In addition to MCF-7 cells, which have been studied extensively in our previous work, we To assess the cell death in response to radiation, breast cancer cell lines were irradiated at different doses (from 0.5 to 32 Gy) followed by viability determination using MTT assay.
As shown in The results suggested that low levels of caspase expression, like that found in MDA-MB-134VI and MDA-MB-415 cells, may contribute to radiation resistance. Obviously, caspase expression was not the sole factor contributing to the resistance. As suggested by these screening data, the contribution of specific ,caspase to radiation resistance should be addressed by specific blocking or overexpression followed by functional assay.
C. Caspase 3 deficiency in breast cancer ------feedback action of caspase 3 on apical factors
The specific aim 3 of this project was to define the biological role of specific caspase deficiencies via specific reconstitution of corresponding caspase. These was planed in ask 4
(months 30-48).
Previously, we reconstituted caspase 3 in MCF-7 breast cancer cells, which are deficient in caspase 3. With the caspase 3 specific cell line model, we have demonstrated that caspase 3 is critical in granzyme B, chemotherapy and radiotherapy induced apoptosis. When we studied the role of caspase 3 in radiation induced apoptosis, our results suggested that caspase 3 might have feedback action on apical factors. Therefore, we performed the following experiments to investigate the feedback action of caspase 3 on doxorubicin and TNF-ca induced apoptosis.
1.
Apical caspases 2, 8, 9 and 10 could be processed by caspase 3 in a pure biochemical system
The major apical factors that are up-stream of caspase 3 in apoptosis cascade are the apical caspases and the factors released from mitochondria (4). We first looked at the feed back action on apical caspases, including caspases 2, 8, 9 and 10 by detecting the activation of these caspases in MCF-7/pV control cells and MCF-7/C3 (caspase 3 reconstituted) cells.
However, even if we could see the difference of apical caspase activation/processing between the two cell lines, the differences could be the result of many direct or indirect reactions. To test whether caspase 3 could directly activate/process these apical caspases, we prepared caspases 2, 8, 9 and 10 by in vitro transcription and translation. These apical caspases were treated with purified caspase 3 individually. As shown in Fig. 8 Appendix A, our result indicated that, in pure biochemical system, apical caspases 2, 8, 9 and 10 could be the substrates of caspase 3, as indicated by the cleavage products. Among them, caspase 9 was a preferred substrate of caspase 3, followed by caspases 2, 8, 9 and 10. The in vitro system demonstrated the biochemical feasibility and specificity of apical caspase activation by caspase 3. However, cellular structure and compartmentalization may also affect the possible action of caspase 3 on apical caspases.
We then detected the activation of caspases 2, 8 and 9 in the lysate made directly from doxorubicin or TNF-cc treated cells (Fig. 13-14, Appendix A) . In whole cell system, processing/activation of caspases 8 and 9 was enhanced in doxorubicin or TNF-ca treated MCF-7/c3 (caspase 3 reconstituted) cells, as compared to caspase 3 deficient MCF-7/pv cells. Caspase 2 activation was minimal in both cell lines under the given conditions. Discrepancy of caspases 2 and 8 between cell free and whole cell systems suggested that the structural compartment might contribute to caspase 3 mediated feedback action.
4.
Feedback action of caspase 3 on cytochrome c release from mitochondria Cytochrome c release from mitochondria is one of the major steps in the activation of effector caspases, such as caspase 3. In our previous study, we found that caspase 3 enhance depolarization of mitochondria (see last year report). Therefore, we hypothesized Some caspases are more important than the others in apoptosis execution. Indeed, our result suggested that the protein levels of caspases 3, 6 and 8 are closely related to apoptotic responses. Therefore, detailed correlation between individual caspase and the resistance should be addressed specifically. Based on our screening results, we will select the cell lines resistant to certain stimuli, like TNF-a or doxorubicin, to investigate the biochemical process between low caspase expression and the resistant phenotype we observed.
Detection of the cleavage of caspase substrates, such as lamin B and DNA fragmentation factor will reveal more information related to this issue. Another aspect to follow is detection of caspase expression in human breast cancer tissues. Although deletion of extremely low levels of caspase expression was not significant in cell lines, our preliminary data from clinical samples found that 17% of breast cancers express low or non-detectable caspase 3. We will extend our detection to gain more information on caspase status in breast cancer samples. Other than deletion of a whole caspase molecule, point mutation should also be considered for further investigation on this issue (5).
By reconstitution of caspase 3 in MCF-7 cells, we have demonstrated that caspase 3 plays a critical role in apoptosis induced by different therapies. It strongly suggested that caspase 3 deficiency would contribute significantly to therapeutic resistance, which is consistent with our hypothesis. Using our cell line model, our results also demonstrated some basic mechanisms in apoptotic pathway, such as the feedback action of caspase 3. Our work is among the leading groups in this area. As planned in specific aim 3, more work on reconstituted cells will be done for in depth study of the role of caspase caspases in breast carcinogenesis and therapeutic resistance.
Although the PI moved to the new institution during the third year of this project, our progress, relative to our original plan, is basically on schedule. At the same time, we also realize that some experiments are needed to complete the original plan or explain the observations we observed from our experiments. If it is necessary, we will apply for a no cost extension to fulfill the necessary experimental design and draw a comprehensive conclusion for this project. Clearly, with the results generated from this project, much more experiments could be followed.
APPENDICES:
Appendix A:
Results generated in the studies of: 35 S labeled caspases 2, 8, 9 and 10 were prepared using in vitro transcription and translation (TNT) system. Approximately 100 ng of TNT product was treated with 100 nM of purified caspase 3 for times indicated. The processing was analyzed by SDS-PAGE and autoradiography. Arrows indicate the cleaved products of pro-enzymes. Relatively, caspase 9 was the preferred substrate of caspase 3, followed by caspases 2, 8 and 10. :'
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